Phase i Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib with Concurrent Radiotherapy for Advanced Head and Neck Cancer

Peter H. Ahn, Mitchell Machtay, Pramila R. Anne, David Cognetti, William M. Keane, Evan Wuthrick, Adam P. Dicker, Rita S. Axelrod

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Phase i Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib with Concurrent Radiotherapy for Advanced Head and Neck Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences